Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from MCK

Drug Distributors, JNJ Agree To Settle $26B Opioid Lawsuits

Distributors McKesson Corporation (NYSE: MCK), AmerisourceBergen Corp (NYSE: ABC), Cardinal Health Inc (NYSE: CAH

5 Best Healthcare Stocks to Buy as a Hedge Against Inflation

5 Best Healthcare Stocks to Buy as a Hedge Against Inflation

The healthcare sector has historically provided a better hedge against inflation than gold because of the inelastic demand for its products and services. Rising healthcare needs of an aging population, integration of advanced technologies, and breakthroughs in clinical trials brighten the sector’s prospects. Therefore, fundamentally-sound and undervalued healthcare stocks Sanofi…

Stabilize Your Portfolio with These 5 High-Quality Stocks

Stabilize Your Portfolio with These 5 High-Quality Stocks

The stock indices are down, heading for a second straight losing week on investor concerns about geopolitical tensions and the Fed’s actions. And the market is expected to remain volatile in the near term. Hence, we think high-quality stocks Merck & Co. (MRK), Archer-Daniels-Midland (ADM), Baxter (BAX), McKesson (MCK), and…

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Buy These 3 Stable Dividend Stocks to Protect Your Portfolio from Increased Volatility

Soaring inflation, heightened geopolitical tensions, and the Fed’s decision to raise interest rates multiple times this year have fostered severe market volatility of late. So, we think investors looking to protect their portfolios from rising volatility should consider adding quality dividend-paying stocks McKesson (MCK), AmerisourceBergen (ABC), and ORIX (IX) to…

Analyst Ratings For McKesson

McKesson (NYSE:MCK) has observed the following analyst ratings within the last quarter:

McKesson's Return on Invested Capital Insights

Pulled from Benzinga Pro data, McKesson (NYSE:MCK) showed a loss in earnings since Q2, totaling $39.00 million. Sales, on the other hand, increased by 3.06% to $68.61 billion during Q3.

McKesson Q3 Earnings Beat Street View, Raises FY22 Outlook Boosted By COVID-19 Vaccine Demand

McKesson Corp (NYSE: MCK) reported

inkl

Read news from The Economist, FT, and more,
with one subscription

Recap: McKesson Q3 Earnings

Recap: McKesson Q3 Earnings

McKesson (NYSE:MCK) reported its Q3 earnings results on Wednesday, February 2, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

McKesson Earnings Preview

McKesson Earnings Preview

McKesson (NYSE:MCK) is set to give its latest quarterly earnings report on Wednesday, 2022-02-02. Here's what investors need to know before the announcement. Analysts estimate that McKesson will likely report an Earnings Per Share (EPS) of $5.42.

1 2 3 4 5

Organisations

US Federal Reserve

Cardinal Health

McKesson Corporation

AmerisourceBergen

Cardinal Health Inc

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Places

243,060 stories

inkl

Read news from The Economist, FT, and more,
with one subscription

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play